Cargando…
Long‐Term Effects of Sglt2 Deletion on Bone and Mineral Metabolism in Mice
Sodium‐glucose cotransporter 2 (SGLT2) inhibitors improve kidney and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM). However, bone fragility has emerged as a side effect in some but not in all human studies. Because use of SGLT2 inhibitors in humans affects mineral metaboli...
Autores principales: | Gerber, Claire, Wang, Xueyan, David, Valentin, Quaggin, Susan E., Isakova, Tamara, Martin, Aline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328801/ https://www.ncbi.nlm.nih.gov/pubmed/34368611 http://dx.doi.org/10.1002/jbm4.10526 |
Ejemplares similares
-
The Extraglycemic Effect of SGLT-2is on Mineral and Bone Metabolism and Bone Fracture
por: Dong, Bingzi, et al.
Publicado: (2022) -
Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease
por: Courbon, Guillaume, et al.
Publicado: (2021) -
DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease
por: Dussold, Corey, et al.
Publicado: (2019) -
Genetic Deletion of Emp2 Does Not Cause Proteinuric Kidney Disease in Mice
por: Donnan, Michael D., et al.
Publicado: (2019) -
Effects of long-term administration of omeprazole on bone mineral density and the mechanical properties of the bone()
por: Yanagihara, Gabriela Rezende, et al.
Publicado: (2015)